Brief: Conduit Pharmaceuticals Forms Review Committee To Investigate Trading Patterns Of Certain Stockholders

CDT Equity

16/08/2024 22:14

Aug 16 (Reuters) - Conduit Pharmaceuticals Inc  CDT.O :
    * CONDUIT PHARMACEUTICALS-  ON OR AROUND AUG 14 WAS MADE
AWARE
THAT ONE OF ITS DIRECTORS, THROUGH UNIT, HAD ENTERED SOME
COLLATERAL PLEDGE AGREEMENTS
    * CONDUIT PHARMACEUTICALS-  COLLATERAL PLEDGE DEALS BY
DIRECTOR
RESULTED IN DISPOSITION OF SUBSTANTIAL AMOUNT OF CO'S SHARES
WITHOUT CO'S KNOWLEDGE
    * CONDUIT PHARMACEUTICALS- BECAME AWARE THAT ABOUT 30
MILLION
SHARES ARE CURRENTLY SUBJECT TO FURTHER THIRD-PARTY PLEDGE DEAL
WITH A STOCKHOLDER OF CO
    * CONDUIT PHARMACEUTICALS - APPOINTED SPECIAL COMMITTEE TO
REVIEW 
MATTERS & DETERMINE ACTION
    * CONDUIT PHARMACEUTICALS - FORMED TRADING REVIEW COMMITTEE
TO
INVESTIGATE TRADING PATTERNS OF CERTAIN OF CO'S STOCKHOLDERS

Source text for Eikon:  ID:n0001493152-24-032854 
Further company coverage:  CDT.O 

 ((Reuters.Briefs@thomsonreuters.com;))